-
Product Insights
NewGamma-Aminobutyric Acid Receptor Subunit Alpha 1 – Drugs In Development, 2024
The Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 pipeline drugs market research report outlays comprehensive information on the Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Metabolic Disorders which include indications of Substance (Drug) Abuse, General Anesthetic Effect, and Hypercholesterolemia. It also reviews key players involved in Gamma-Aminobutyric...
-
Product Insights
NewGamma-Aminobutyric Acid Type A Receptor Subunit Gamma – Drugs In Development, 2024
The Gamma-Aminobutyric Acid Type A Receptor Subunit Gamma pipeline drugs market research report outlays comprehensive information on the Gamma-Aminobutyric Acid Type A Receptor Subunit Gamma targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Metabolic Disorders which include indications of Sedation, General Anesthetic Effect, and Hypercholesterolemia. It also reviews key players involved in Gamma-Aminobutyric...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BX-1000 in Anesthetic Effect
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BX-1000 in Anesthetic Effect report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BX-1000 in Anesthetic Effect Drug Details: BX-1000 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BX-2000 in Anesthetic Effect
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BX-2000 in Anesthetic Effect report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BX-2000 in Anesthetic Effect Drug Details: BX-2000 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cipepofol in General Anesthetic Effect
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cipepofol in General Anesthetic Effect report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cipepofol in General Anesthetic Effect Drug Details: Cipepofol (Si Shu...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Esketamine Hydrochloride in General Anesthetic Effect
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Esketamine Hydrochloride in General Anesthetic Effect report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esketamine Hydrochloride in General Anesthetic Effect Drug Details: Esketamine...
-
Product Insights
NewAirway Management Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Airway Management Pipeline Market Report Overview Airway management refers to medical procedures performed for the prevention or alleviation of any obstruction in the airway. Airway management procedures are performed to open a pathway for maintaining or re-storing proper gas exchange between a patient's lungs and the atmosphere. This is accomplished with the use of an infraglottic device (Endotracheal tubes) supraglottic device (Laryngeal mask) or surgical method (Tracheostomy). The devices used for airway management are referred to as airway management devices....
-
Product Insights
NewDentsply Sirona Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Dentsply Sirona Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instruments and materials, prophylaxis paste, dental sealants, ultrasonic scalers and crown and bridge materials. The company offers dental injectable anesthetics, impression materials, orthodontic appliances, dental...
-
Product Insights
NewNeuroWave Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our NeuroWave Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. NeuroWave Systems Inc (NeuroWave) is a medical device company. It develops and commercializes brain monitors with electrodes. The company offers various products such as neurosense monitor and easyprep electrodes. Its NeuroSENSE monitor is a bilateral brain monitor, which measure anesthetic effects on the brain and respond instantaneously to changes in patient state. NeuroWave's EasyPrep electrodes is a proprietary disposable...
-
Product Insights
NewPacira BioSciences Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Pacira BioSciences Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute...